Oxurion (Euronext Brussels: OXUR - formerly known as ThromboGenics) is a biopharmaceutical company developing treatments to preserve vision in patients with diseases affecting the back of the eye. The company has built a diverse portfolio of disease-modifying therapies, including treatments for diabetic eye disease, a leading cause of blindness in people of working age worldwide.

Biotechnology

Oxurion

Oxurion's headquarters in Leuven, Belgium

Grace Chang

Andy De Deene

Kathleen Paisley

Linda Knott

An Huysmans

Philippe B.

Alfred Aronson

Eva Padgett

Clara Song

Samuel Darcheville

Astrid de Vriese

François le Floch

Patrik De Haes

David Guyer

Baron Philippe Vlerick

Adrienne Graves

Emmanuèle Attout

Description

People

Jobs